Sort
30,917 grants matching “tumor microenvironment”
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
$750,000Peter A Jones · University Of Southern California · P30 · FY2006 · CA
University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune Systems
$750,000Richard D Schulick · University Of Colorado Denver · P30 · FY2024 · CA
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
$750,000David M Spencer · Baylor College Of Medicine · U01 · FY2009 · CA
Collaborative Research: CPS: Medium: A CPS approach to tumor immunomodulation; sensing, analysis, and control to prime tumors to immunotherapy
$750,000Bala Natarajan · Kansas State University · · FY2021 · CSE
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics
$750,000Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2019 · CA
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics
$750,000Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2020 · CA
Immunological approaches to overcoming therapy resistance in human tumors
$749,999Dario C. Altieri · Wistar Institute · P30 · FY2024 · CA
Cancer Center Support Grant
$749,690Robert L Ferris · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · CA
Immune determinants of progression from Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma by precision multiplexed imaging
$749,410Matthew Spitzer · University Of California, San Francisco · R01 · FY2022 · DE
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
$749,353Wei-Jun Qian · Battelle Pacific Northwest Laboratories · R01 · FY2019 · DK
Understanding the role of metabolism in cancer
$749,322Matthew G. Vander Heiden · Massachusetts Institute Of Technology · R35 · FY2023 · CA
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.
$749,308Katerina Abigail Politi · Yale University · U01 · FY2022 · CA
Decoding and reprogramming T cells through synthetic biology for cancer immunotherapy
$749,187Alexander Marson · J. David Gladstone Institutes · R01 · FY2025 · CA
Biostatistics Core
$749,167Peter A Jones · University Of Southern California · P30 · FY2013 · CA
A Platform Technology to Genetically Reprogram Cancer Cells for Enhanced Immunotherapy
$749,156Stephany Yi Tzeng · Johns Hopkins University · R37 · FY2025 · CA
Engineered Invasive Human Breast Tumors with Integrated Capillaries and Lymphatics
$748,985Joe Y Tien · Boston University (Charles River Campus) · U01 · FY2020 · CA
Microenvironmental regulation of glioblastoma radiosensitivity
$748,682Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Project 1 - Evolutionary and ecological dynamics of tumor-host interactions
$748,658Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2018 · CA
Michigan Center for Translational Cancer Proteogenomics
$748,417Alexey I Nesvizhskii · University Of Michigan At Ann Arbor · U24 · FY2025 · CA
PyroTIMER Technology: Enabling T-Cell Persistence in Immunosuppressive Tumor Microenvironments
$748,337Archis Bagati · Pyrojas Inc · R44 · FY2024 · CA
PESO: Engineered Platforms to Investigate Molecular Determinants of Tumor Metastasis to Targeted Niche Sites
$748,250Joyce Y Wong · Trustees Of Boston University · · FY2012 · MPS
Optimizing radiation therapy through the manipulation of glutamine metabolism
$748,125Julie Kristina Schwarz · Washington University · R01 · FY2025 · CA
Dissecting the Source and Mechanisms of IL-17-Mediated Modulation of Pancreatic Tumorigenesis
$748,012Florencia McAllister · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Systems biology of intratumoral heterogeneity in glioblastoma
$747,647Nitin S Baliga · Institute For Systems Biology · R01 · FY2023 · CA
Mechano-chemical regulation of the microenvironmental niche in melanoma
$747,231Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA